Cefazolin-Induced Thrombocytopenia in a Patient with Polycythemia Vera Following Coronary Artery Bypass.
Racha BoulosKatja TurnerSamiya SaklayenWilliam J PerezManoj H IyerPublished in: Seminars in cardiothoracic and vascular anesthesia (2021)
Cefazolin is an antibiotic that is commonly administered perioperatively to reduce the risk of surgical site infections. Cephalosporins have a well-established safety profile, but have been associated with thrombocytopenia and neutropenia due to their myelosuppressive effects. While this effect may be benign in healthy patients undergoing minor surgery, it can be detrimental in patients with underlying hematologic disorders presenting for open-heart surgery. Herein, we discuss the first case in the literature of cefazolin-induced thrombocytopenia and severe coagulopathy in a patient with polycythemia vera (PCV) during a coronary artery bypass-grafting surgery.
Keyphrases
- coronary artery bypass
- percutaneous coronary intervention
- coronary artery bypass grafting
- minimally invasive
- case report
- patients undergoing
- coronary artery disease
- high glucose
- acute coronary syndrome
- diabetic rats
- heart failure
- systematic review
- drug induced
- atrial fibrillation
- surgical site infection
- oxidative stress
- stress induced